<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-UKFVEIT9</identifier><date>2022</date><creator>Mesti, Tanja</creator><relation>documents/doc/U/URN_NBN_SI_doc-UKFVEIT9_001.pdf</relation><relation>documents/doc/U/URN_NBN_SI_doc-UKFVEIT9_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 33-36</format><identifier identifier_type="COBISSID_HOST">133415683</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-UKFVEIT9</identifier><language>slv</language><publisher publisher_location="Ljubljana">Katedra za onkologijo</publisher><publisher publisher_location="Ljubljana">Onkološki inštitut Ljubljana, Sekcija za internistično onkologijo</publisher><source>Možganski tumorji</source><rights>InC</rights><subject language_type_id="slv">centralno živčevje</subject><subject language_type_id="slv">možganski tumorji</subject><subject language_type_id="slv">radioterapija</subject><title>Clinical significance of molecular features</title><title>Klinični pomen molekularnih lastnosti</title></Record>